FOLR1 and neoplasm: It is worth noting that anti-FOLR1 CAR candidate C induced a temporary weight loss (Supplementary Figure S5c) correlating with delayed tumor elimination (Figure 3b,c) and higher IFN-γ and GM-CSF secretion (Figure 3h).